Bendamustine plus rituximab is effective and has a favorable toxicity profile in the treatment of mantle cell and low-grade non-Hodgkin's lymphoma
収録刊行物
-
- J Clin Oncol.
-
J Clin Oncol. 23 3383-3389, 2005